作为多功能抗癌剂的异氨酸:分子机制,药理见解和治疗潜力
Pritam Sarkar1, Nasrin Sultana1, Prottoy Kumar Debnath1
1Pharmacy Discipline, Khulna University, Khulna, Bangladesh.
Archiv der Pharmazie
|September 3, 2025
概括
通过抑制瘤生长和诱导亡, 需要进一步的研究以优化其使用并解决更容易获得的治疗方法的毒性.
科学领域:
- 癌症学
- 药理学
- 药物的转化
背景情况:
- 传统的癌症疗法面临诸如耐药性,副作用和高成本等挑战.
- 药物重新使用为从现有药物中鉴别出新型抗癌药物提供了一个有前途的途径.
研究的目的:
- 审查异氨酸的化学成分,药物动力学,毒性和抗癌机制.
- 探索支持异氨酸在癌症治疗中的临床和临床前证据.
主要方法:
- 在癌症中对异氨酸进行临床前和临床研究的文献综述.
- 分析异氨酸的分子机制,包括受体激活和途径调节.
主要成果:
- 它有效地抑制了瘤细胞的生长,诱导了亡,并调节了各种癌症的分化.
- 这些机制包括视网膜酸受体 (RAR) 的激活和瘤途径的抑制.
- 与异氨酸联合治疗具有协同作用,可能提高疗效并减少副作用.
结论:
- 通过多种机制显示出异氨酸作为抗癌剂的显著潜力.
- 需要进一步的研究来优化剂量,配方,并解决更广泛的临床应用的毒性.
- 药物重新利用异丁胺为更具成本效益的癌症疗法提供了途径.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659


